Ironwood Pharmaceuticals, Inc. (the "Company") (Nasdaq: IRWD), a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI) and rare ...
As set forth in the Notice, as of March 25, 2025, the 30 trading-day average market capitalization of the Company was approximately $37.9 million and the Company’s last reported stockholders’ equity ...
As senior officials deny wrongdoing, rank-and-file national-security personnel warn of a damaging double standard.
People on the highest rates of disability benefits will be due nearly £750 each month over the 2025/26 financial year.
Under the terms of the contract, LOBO EV Technologies will deliver a total of 5,500 electric vehicles to Ukraine, including 4,000 standard electric bicycles and 1,500 three-wheeled EVs (Model: XIAODOU ...
Senator Akpoti-Uduaghan has petitioned the LPDC, seeking the disbarment of Senate Ethics Chair Nedamwem Imasuen over fraud ...
The last time Barron’s convened a Tech Roundtable—in August 2023—generative artificial intelligence was in its honeymoon ...
The SEC issued new guidance on how an issuer wishing to engage in general solicitation under Rule 506(c) may satisfy the rule ...
Announcing accretive transaction to consolidate a 100% interest in Copper Mountain, further increasing Hudbay’s exposure to a ...
Spyre Therapeutics, Inc. (the "Company" or "Spyre"), a clinical-stage biotechnology company advancing best-in-class antibody engineering, dose optimization, and rational therapeutic combinations for ...
Kairos Pharma, Ltd. , a clinical-stage biopharmaceutical company, highlights activity at recent scientific conferences and announces participation in future events. Highlights include: March 12, 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results